Skip to main content
Displaying 1 - 12 of 14
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Tools for early detection of metabolic risk in MAFLD
Webcasts
View
Metabolism, Alcohol & Toxicity
Insights from the SIRIUS project – a population-wide liver disease screening program in Slovakia
Webcasts
View
Metabolism, Alcohol & Toxicity
Early screening of metabolic risk – the pharmacists’ perspective
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Sanofi: "Global Liver Health Forum 2023" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
To what extent can HRQoL impact clinical outcomes in MAFLD?
Webcasts
View
Metabolism, Alcohol & Toxicity
Essential phospholipids in the liver health landscape – clinical evidence
Webcasts
View
Metabolism, Alcohol & Toxicity
MAFLD – the importance of early identification and interventio
Webcasts
View
Metabolism, Alcohol & Toxicity
MAFLD-associated metabolic risks in obesity and diabetes – insights from clinical practice
Webcasts
View
Metabolism, Alcohol & Toxicity
Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" (Complete Session)
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy